Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Dihexa has demonstrated remarkable results in preclinical (animal) studies, including significant improvements in synaptic density, neuronal survival, and spatial memory in rodent models of cognitive impairment
Yes, many users choose to start with IV treatments for faster results and maintain progress with oral supplements
Meet Our Experts Kelly Kennedy, RDN, LDN Medical Reviewer Kelly Kennedy is a licensed dietitian-nutritionist with over 14 years of experience in digital media
developmental code PNB-0408) is a synthetic small oligopeptide derived from angiotensin IV (AngIV), engineered to overcome AngIVs limitations as a research tool by adding lipophilic modifications that confer oral bioavailability and blood-brain barrier permeability
Noctor G, Mhamdi A, Chaouch S, Han Z, Neukermans J, Marquez-Garcia B, et al
US$ 27.96
US$ 28.28
US$ 29.73
US$ 23.91
